1. Home
  2. MBIO vs QCLS Comparison

MBIO vs QCLS Comparison

Compare MBIO & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.39

Market Cap

4.1M

Sector

Health Care

ML Signal

N/A

Logo Q/C Technologies Inc.

QCLS

Q/C Technologies Inc.

HOLD

Current Price

$0.49

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
QCLS
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.4M
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
MBIO
QCLS
Price
$0.39
$0.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.3K
★ 1.3M
Earning Date
11-06-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 98.99
22.33
EPS
★ N/A
N/A
Revenue
N/A
★ $3,929,527.00
Revenue This Year
N/A
N/A
Revenue Next Year
$405.45
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 32.71
52 Week Low
$0.37
$0.42
52 Week High
$1.52
$10.44

Technical Indicators

Market Signals
Indicator
MBIO
QCLS
Relative Strength Index (RSI) 29.78 27.01
Support Level N/A $0.42
Resistance Level $0.56 $1.18
Average True Range (ATR) 0.03 0.05
MACD -0.00 0.04
Stochastic Oscillator 10.84 2.33

Price Performance

Historical Comparison
MBIO
QCLS

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: